Copy the page URI to the clipboard
Kale, Dinar and Huzair, Farah
(2017).
DOI: https://doi.org/10.1080/09537325.2016.1276283
Abstract
This paper examines heterogeneity in the response of Indian firms to the emergence of a new segment in the pharmaceutical generics market – biosimilars. The necessary diversity of the knowledge base and regulatory requirements underlying biosmilar products have created significant technological capability and market access challenges for Indian firms. This is but the latest development which adds to an existing catalogue of challenges including the decline of the traditional generics markets, regulatory hurdles in advanced country markets and failures in managing new drug development. Using case studies of three Indian firms we show that dynamic managerial capability is a key driver of heterogeneity in learning processes involved in acquisition of technological capabilities for biosimilars and market access strategies. It further highlights the important role of pre-existing capabilities in enabling and constraining the development of new biosimilar capabilities.
Viewing alternatives
Download history
Metrics
Public Attention
Altmetrics from AltmetricNumber of Citations
Citations from DimensionsItem Actions
Export
About
- Item ORO ID
- 48633
- Item Type
- Journal Item
- ISSN
- 1465-3990
- Keywords
- India; dynamic capabilities; pharmaceutical industry; heterogeneity
- Academic Unit or School
-
Faculty of Arts and Social Sciences (FASS) > Social Sciences and Global Studies > Development
Faculty of Arts and Social Sciences (FASS) > Social Sciences and Global Studies
Faculty of Arts and Social Sciences (FASS)
Faculty of Science, Technology, Engineering and Mathematics (STEM) > Engineering and Innovation
Faculty of Science, Technology, Engineering and Mathematics (STEM) - Research Group
-
Innovation, Knowledge & Development research centre (IKD)
International Development & Inclusive Innovation
Health and Wellbeing PRA (Priority Research Area)
Institute for Innovation Generation in the Life Sciences (Innogen) - Copyright Holders
- © 2017 Informa UK Limited, trading as Taylor & Francis Group
- Depositing User
- Dinar Kale